Theodora Kunovac Kallak

researcher at Department of Women's and Children's Health, Research group; Reproductive Health

Visiting address:
Rudbeckslaboratoriet Hus R3 plan 1
Dag Hammarskjölds väg 20
SE-752 37 Uppsala
Postal address:
Akademiska sjukhuset
751 85 UPPSALA

deputy director at The Centre for Reproductive Biology in Uppsala (CRU)

Postal address:
Box 7054
750 07 UPPSALA

Short presentation

I completed my PhD in medical sciences at Uppsala University in 2015. I am currently working as postdoctoral researcher at the Department of Women’s and Children’s Health, Uppsala University, and I am one of the assistant directors of the Centre for Reproductive Biology in Uppsala. My research activities cover genitourinary symptoms of menopause, infertility, gynecological cancers, maternal health during pregnancy and the effect of the future health of the offspring.

Also available at

My courses


here are more than 80 000 Swedish women living with breast cancer and approximately 75% of all breast cancers occur in postmenopausal women and 80% of these cancers are hormone receptor positive. Adjuvant endocrine treatments are used to induce estrogen deprivation, either at the receptor level (tamoxifen) or by inhibiting estrogen biosynthesis (aromatase inhibitors). The use of tamoxifen and aromatase inhibitors has, however, been associated with gynecological side effects and worsening of menopausal symptoms. The aim with my project is to examine biochemical factors such as steroid hormone receptors, aquaporins and inflammatory factors, which may be involved in gynecological side effects such as vaginal atrophy, dryness and pain, in estrogen deprived postmenopausal breast cancer patients and in aged-matched women with or without estrogen therapy.


Please contact the directory administrator for the organization (department or similar) to correct possible errors in the information.